cfSNV

cfSNV detects somatic single-nucleotide variants in cell-free DNA sequencing data to enable sensitive mutation identification from liquid biopsy samples.

Key Features:

• Somatic Mutation Detection in cfDNA: Identifies somatic single-nucleotide variants from cell-free DNA sequencing datasets containing low tumor fractions.
• cfDNA-Specific Variant Calling: Incorporates computational strategies tailored to the distinct characteristics of circulating cell-free DNA.
• Whole-Exome Sequencing Compatibility: Detects mutations from cfDNA whole-exome sequencing datasets at sequencing coverage levels of approximately ≥200×.
• Efficient Mutation Calling: Processes preprocessed whole-exome sequencing datasets with moderate computational resources.

Scientific Applications:

• Liquid Biopsy Mutation Profiling: Detects tumor-derived somatic mutations in circulating cell-free DNA from blood samples.
• Cancer Genomics Research: Supports identification of somatic variants for cancer diagnosis, treatment monitoring, and therapy response evaluation.

Methodology:

cfSNV analyzes sequencing data from cell-free DNA and applies computational methods optimized for low tumor fraction samples to detect somatic single-nucleotide variants from whole-exome sequencing datasets.